A low-sodium diet potentiates the effects of losartan in type 2 diabetes.
about
Effect of longer-term modest salt reduction on blood pressureAltered dietary salt intake for preventing and treating diabetic kidney diseaseInteractions between kidney disease and diabetes: dangerous liaisonsMeta-Analysis of the Effect of Dietary Sodium Restriction with or without Concomitant Renin-Angiotensin-Aldosterone System-Inhibiting Treatment on AlbuminuriaCo-occurrence of diabetes and hypertension: pattern and factors associated with order of diagnosis among nigerians.Diabetic nephropathy - complications and treatment.Dietary salt intake and mortality in patients with type 2 diabetes.Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: a single-blinded randomized, controlled trialThe reno-protective role of AT(1)-receptor blockers.A comprehensive review on salt and health and current experience of worldwide salt reduction programmes.Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trialSodium intake, ACE inhibition, and progression to ESRD.The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney DiseaseRenin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences.Trends in adherence to dietary recommendations among Korean type 2 diabetes mellitus patients.Impact of Lifestyle Modification on Diabetic Kidney DiseaseEffects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan.Why is blood pressure so hard to control in patients with type 2 diabetes?Effects of salt supplementation on the albuminuric response to telmisartan with or without hydrochlorothiazide therapy in hypertensive patients with type 2 diabetes are modulated by habitual dietary salt intake.Sodium and Its Role in Cardiovascular Disease - The Debate Continues.Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.Which antihypertensive drugs are the most nephroprotective and why?Improving the efficacy of RAAS blockade in patients with chronic kidney disease.Effects of high- and low-sodium diets on ambulatory blood pressure in patients with hypertension receiving aliskiren.Sodium intake and excretion in individuals with type 2 diabetes mellitus: a cross-sectional analysis of overweight and obese males and females in Australia.Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetes.Relationship between urinary sodium excretion and serum aldosterone in patients with diabetes in the presence and absence of modifiers of the renin-angiotensin-aldosterone system.Relapse or worsening of nephrotic syndrome in idiopathic membranous nephropathy can occur even though the glomerular immune deposits have been eradicated.Medications that cause weight gain and alternatives in Canada: a narrative review
P2860
Q24197603-83E24E49-DF56-4E5E-8746-7F8442E78F25Q24235479-DF2C7A27-0EF2-44E2-81DA-A3E71F7F2CB9Q26740630-44A1D6E7-3249-425F-8E33-04158EF51F65Q28085248-61BAD7F0-795A-4690-8BDE-57B3E11E0D7BQ33950267-C0617F2D-5F5D-473A-B08E-33D716D15A55Q34387952-957861DE-6C33-436C-9F52-C99FC6797F23Q34583392-1CDCCC81-69CA-4783-B63E-76402B9B0C22Q34629667-FA96DADD-1598-4F78-AA2E-E8A3008745D1Q34761197-6E0E036A-147B-4EDD-A918-947914A98DF2Q34911239-421B5981-3A65-468F-86C0-0478AF8B3466Q35128415-90DF22A0-4A38-4135-A840-1CAA70805F41Q35720736-2EBB7C01-6085-4BB5-A255-AD85B7A18C6CQ35914820-838FD202-E5C3-421C-94DB-D8584D5231C1Q36329456-A54E9FAD-F497-4849-9DCC-68ED54768959Q36340111-B8D31ACE-1BC5-486D-BDA2-0EC2E799F907Q36458435-12017CA0-17A7-4310-891B-59969472FDC6Q36662162-D0DAA0B2-FF98-42AD-A7BA-3066EA8AAFDCQ36904456-F5A91D52-F692-4EEE-8016-10BA45ADD83BQ37269455-1F7F38CC-F220-449C-9FA6-30C9F2EA4CE1Q37528633-1B56419F-AA2A-4F79-B546-C1F8205321CAQ37598918-623C60F7-97F3-4C87-9527-C13868B33A1EQ37803235-97A2B6AF-F0D8-492C-8F68-868138F0C072Q38068099-32C19E3E-0388-48A3-BA5F-9F0AA9CD4D0AQ42874814-B401C46E-45EA-4BDA-A6CB-FE5CA2D8EBFDQ45363830-77AAA153-7C4E-41C7-9E9B-273123370E51Q46335942-C103E1E0-1D3C-454F-AF28-CDE1BF3EC1BCQ47960338-A22C4F73-60BE-4FC1-B5A2-4ED0BD45EEC0Q55470645-A272DDBF-83C1-4C33-A286-5ABF3315F314Q58729864-5250E2F7-AB34-40AD-8DD2-127706356C12
P2860
A low-sodium diet potentiates the effects of losartan in type 2 diabetes.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
A low-sodium diet potentiates the effects of losartan in type 2 diabetes.
@en
A low-sodium diet potentiates the effects of losartan in type 2 diabetes.
@nl
type
label
A low-sodium diet potentiates the effects of losartan in type 2 diabetes.
@en
A low-sodium diet potentiates the effects of losartan in type 2 diabetes.
@nl
prefLabel
A low-sodium diet potentiates the effects of losartan in type 2 diabetes.
@en
A low-sodium diet potentiates the effects of losartan in type 2 diabetes.
@nl
P2093
P356
P1433
P1476
A low-sodium diet potentiates the effects of losartan in type 2 diabetes.
@en
P2093
Amynta L Baxter
Christine A Houlihan
David J Casley
George Jerums
Mark E Cooper
Sianna Panangiotopoulos
Terri J Allen
P304
P356
10.2337/DIACARE.25.4.663
P407
P577
2002-04-01T00:00:00Z